Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
O6-Benzylguanine + BCNU + RT in Newly Diagnosed GBM
NCT00017147Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2001
- Primary completion
- May 2006
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of 6-benzylguanine in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by SWOG Cancer Research Network. Started Sep 2001; status: completed.
02
Drugs
6-benzylguanine
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00017147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017147.